http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004535399-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20 |
| filingDate | 2002-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2004-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2004535399-A |
| titleOfInvention | Dihydroimidazo [5,1-a] -β-carboline derivatives, their preparation, and their application as pharmaceuticals |
| abstract | The present invention relates to a compound of the general formula (I) wherein, in particular, R 1 , R 2 , R 3 , R 4 , R 6 and R 7 are the same or different and are each independently a hydrogen, a halogen atom, An alkyl, hydroxy, alkoxy, trihalogenoalkyl, alkylamino, dialkylamino, aryl, arylalkyl, carboxy, alkylcarbonyloxy, acyl, aryloxy or arylalkoxy group, and R 5 is a hydrogen atom, an alkyl or arylalkyl group. A) dihydroimidazo [5,1-a] -β-carboline compounds, and isomers thereof, and addition salts thereof with pharmaceutically acceptable acids. The compounds of the present invention are used as pharmaceuticals, especially as hypnotics. |
| priorityDate | 2001-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 116.